Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies
FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG): Patient Selection, Tailoring Dosing Regimens, Updated Disease Management Paradigms
Early, Optimal Management of CKD and Cardiorenal Disease to Prevent Disease Progression and Improve Outcomes
Hypertrophic Cardiomyopathy: New Evidence, Updated Guidelines to Support Optimal Management
Journal Club: The 2023 WHF Consensus Document on ATTR-CM
Code ICH: A Call to Action
Notable Highlights “LIVE” from ACC24: Advances in Non-Statin Lipid Therapy